Literature DB >> 23472768

History of syncope in the cardiac literature.

David S Cannom1.   

Abstract

The rich cardiology literature of the past 100 years in which the most important forms of syncope are described - including vasodepressor syncope, postural orthostatic hypotension, and Morgagni-Stokes-Adams syncope - is fascinating. These conditions were of interest to some of our most astute clinicians who were also excellent writers. We thus have available for review the remarkable description of patients with these entities written by clinicians such as Soma Weiss, Sir Thomas Lewis, Laurence Ellis, David Sherf, Milton Shy, and Glenn Drager. In their detailed clinical descriptions we identify the pertinent symptoms and signs we see in our patients today years later. A group of brilliant basic physiologists and cardiologists was able to explain the altered physiology responsible for the clinical presentations of syncope patients. Basic investigations were done by investigators such as Arnold Weissler, James Warren, J. Erlanger and clinical cardiologists including John Parkinson, Cornelio Papp, and William Evans to name just a few. Between the early precise clinical descriptions and the subsequent thorough definition of the altered physiology, a surprisingly complete understanding of these clinical entities was established 50 years ago. It took another generation before clinicians developed methods of caring for patients with these clinical entities. The development of implantable devices, e.g., pacemakers and defibrillators, for use in Morgagni-Adams-Stokes attacks is the best example of curative therapies catching up with clinical diagnoses. Other more simple relevant therapies were developed for patients with vasodepressor syncope and postural orthostatic hypotension. Finally, the development and acceptance of clinical guidelines for the treatment of these conditions brought the original clinical observations and description of altered physiology into focus and ushered in a new generation of improved care for these patients.
Copyright © 2013. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23472768     DOI: 10.1016/j.pcad.2012.11.013

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  5 in total

1.  Neurohormones in Vasovagal Syncope: Are They Important?

Authors:  Noah N Williford; Mark W Chapleau; Brian Olshansky
Journal:  J Am Heart Assoc       Date:  2019-06-18       Impact factor: 5.501

2.  Clinical Features of Patients Undergoing the Head-Up Tilt Test and Its Safety and Efficacy in Diagnosing Vasovagal Syncope in 4,873 Patients.

Authors:  Lingping Xu; Xiangqi Cao; Rui Wang; Yichao Duan; Ye Yang; Junlong Hou; Jing Wang; Bin Chen; Xianjun Xue; Bo Zhang; Hua Ma; Chaofeng Sun; Fengwei Guo
Journal:  Front Cardiovasc Med       Date:  2022-01-12

3.  Etiology of syncope in hospitalized patients.

Authors:  Mehrdad Saravi; Alijan Ahmadi Ahangar; Mohammad Masood Hojati; Ebrahim Valinejad; Ahmad Senaat; Reza Sohrabnejad; Mohammad Reza Khosoosi Niaki
Journal:  Caspian J Intern Med       Date:  2015

4.  The Current Indication for Pacemaker in Patients with Cardioinhibitory Vasovagal Syncope.

Authors:  Rose Mary Ferreira Lisboa da Silva
Journal:  Open Cardiovasc Med J       Date:  2016-08-26

5.  Diagnostic accuracy of evaluation of suspected syncope in the emergency department: usual practice vs. ESC guidelines.

Authors:  Veera K van Wijnen; Reinold O B Gans; Wouter Wieling; Jan C Ter Maaten; Mark P M Harms
Journal:  BMC Emerg Med       Date:  2020-08-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.